These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9770195)

  • 1. Monitoring of serum aminoglycoside levels with once-daily dosing.
    Paterson DL; Robson JM; Wagener MM; Peters M
    Pathology; 1998 Aug; 30(3):289-94. PubMed ID: 9770195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens.
    Barletta JF; Johnson SB; Nix DE; Nix LC; Erstad BL
    J Trauma; 2000 Nov; 49(5):869-72. PubMed ID: 11086778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients.
    Koo J; Tight R; Rajkumar V; Hawa Z
    Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
    Lim AK; Mathanasenarajah G; Larmour I
    Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The aminoglycoside panel: a new approach to monitoring aminoglycoside therapy.
    Gorsky JE; Latts JR
    Ther Drug Monit; 1983 Jun; 5(2):169-72. PubMed ID: 6879640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing dosage adjustment methods for once-daily tobramycin in paediatric and adolescent patients with cystic fibrosis.
    Hennig S; Holthouse F; Staatz CE
    Clin Pharmacokinet; 2015 Apr; 54(4):409-21. PubMed ID: 25403847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience of once-daily aminoglycoside dosing using a target area under the concentration-time curve.
    Barclay ML; Duffull SB; Begg EJ; Buttimore RC
    Aust N Z J Med; 1995 Jun; 25(3):230-5. PubMed ID: 7487691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients.
    Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB
    Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing.
    Demczar DJ; Nafziger AN; Bertino JS
    Antimicrob Agents Chemother; 1997 May; 41(5):1115-9. PubMed ID: 9145878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy.
    Prins JM; Weverling GJ; de Blok K; van Ketel RJ; Speelman P
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2494-9. PubMed ID: 8913452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations.
    Coulthard KP; Peckham DG; Conway SP; Smith CA; Bell J; Turnidge J
    J Cyst Fibros; 2007 Apr; 6(2):125-30. PubMed ID: 16829216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuries.
    Hoey LL; Tschida SJ; Rotschafer JC; Guay DR; Vance-Bryan K
    J Burn Care Rehabil; 1997; 18(2):116-24. PubMed ID: 9095420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
    Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
    Prescott WA
    Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Easier monitoring of aminoglycoside therapy with once-daily dosing schedules.
    Prins JM; Koopmans RP; Büller HR; Kuijper EJ; Speelman P
    Eur J Clin Microbiol Infect Dis; 1995 Jun; 14(6):531-5. PubMed ID: 7588829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriateness of a 4 mg/kg gentamicin or tobramycin loading dose in post-operative septic shock patients.
    Oparaoji EC; Siram S; Shoheiber O; Cornwell EE; Mezghebe HM
    J Clin Pharm Ther; 1998 Jun; 23(3):185-90. PubMed ID: 9831969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
    Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
    Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring of tobramycin: once-daily versus twice-daily dosage schedules.
    Sánchez-Alcaraz A; Vargas A; Quintana MB; Rocher A; Querol JM; Poveda JL; Hermenegildo M
    J Clin Pharm Ther; 1998 Oct; 23(5):367-73. PubMed ID: 9875685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.